21 U.S.C. § 41 to 50
Repealed. Pub. L. 104–128, § 2, Apr. 9, 1996, 110 Stat. 1198
Repealed. Pub. L. 104–128, § 2, Apr. 9, 1996, 110 Stat. 1198
Search
Search by citation or keyword across the current edition within Title 21.
Repealed. Pub. L. 104–128, § 2, Apr. 9, 1996, 110 Stat. 1198
Repealed. Pub. L. 104–128, § 2, Apr. 9, 1996, 110 Stat. 1198
Repealed. Pub. L. 98–509, title III, § 301(d), Oct. 19, 1984, 98 Stat. 2364
Repealed. Pub. L. 98–509, title III, § 301(d), Oct. 19, 1984, 98 Stat. 2364
Designation of United States Anti-Doping Agency
Designation of United States Anti-Doping Agency
Standards for regenerative medicine and regenerative advanced therapies
Standards for regenerative medicine and regenerative advanced therapies
Expanded access policy required for investigational drugs
Expanded access policy required for investigational drugs
Authority to assess and use human generic drug fees
Authority to assess and use human generic drug fees
Tolerances and exemptions for pesticide chemical residues
Tolerances and exemptions for pesticide chemical residues
Registration of producers of drugs or devices
Registration of producers of drugs or devices
General provisions respecting control of devices intended for human use
General provisions respecting control of devices intended for human use
Countermeasure development, review, and technical assistance
Countermeasure development, review, and technical assistance